Medicare Enrolled
Dr. Lee Sheinkopf, MD
Allergy & Immunology · Los Angeles, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Sheinkopf from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sheinkopf?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sheinkopf
Dr. Lee Sheinkopf is an allergy & immunology specialist in Los Angeles, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Sheinkopf performed 10,585 Medicare services across 952 unique beneficiaries.
Between the years covered by Open Payments, Dr. Sheinkopf received a total of $16,383 from 40 pharmaceutical and/or device companies across 723 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in allergy & immunology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sheinkopf is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 17% volume in CA
$16,383 industry payments
Medicare Practice Summary
Medicare Utilization ↗10,585
Medicare services
Top 17% in CA for allergy & immunology
952
Unique beneficiaries
$25
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~557 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Omalizumab injection (Xolair) for asthma/allergy | 5,385 | $30 | $46 |
| Allergy skin test A diagnostic test performed to identify specific allergies by applying or introducing allergenic extracts to the body. The procedure measures the patient's immune response to various potential allergens. |
2,897 | $4 | $8 |
| Allergy immunotherapy preparation A professional service involving the preparation and administration of one or more antigens. |
460 | $14 | $20 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
452 | $107 | $145 |
| Middle ear function test A diagnostic test used to evaluate how well the middle ear is functioning. |
330 | $15 | $30 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
313 | $12 | $30 |
| Allergy injection therapy, multiple injections A professional service involving the administration of multiple allergen injections. |
240 | $10 | $24 |
| COVID-19 immunoassay detection test A laboratory test that uses an immunoassay method to detect the presence of severe acute respiratory syndrome coronavirus 2 (COVID-19) through direct visual observation. |
109 | $41 | $50 |
| Nitric oxide gas level test A test that measures the level of nitric oxide gas in the body. |
91 | $18 | $30 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
63 | $135 | $275 |
| Allergen injection administration Professional service for the administration of a single allergen injection. |
50 | $9 | $20 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
41 | $20 | $28 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
39 | $24 | $65 |
| Airflow rate measurement test A test that measures the rate of airflow. This procedure assesses how quickly air moves. |
39 | $35 | $75 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
23 | $34 | $95 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
15 | $72 | $80 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
15 | $34 | $40 |
| Nasal endoscopy A diagnostic procedure that uses a thin, lighted tube to examine the inside of the nasal passages. |
12 | $177 | $250 |
| Inhalation treatment for acute airway obstruction, first hour This procedure involves administering inhaled medication to treat acute airway obstruction during the first hour of treatment. |
11 | $48 | $60 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$16,383
Total received (2018-2024)
Avg $2,340/year across 7 years
Top 17% in CA for allergy & immunology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
723
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,328 (99.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$55 (0.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,402
2023
$2,659
2022
$3,269
2021
$2,312
2020
$1,220
2019
$2,233
2018
$2,288
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Regeneron Healthcare Solutions, Inc.
$406
Amgen Inc.
$320
GlaxoSmithKline, LLC.
$267
AstraZeneca Pharmaceuticals LP
$264
Grifols USA, LLC
$192
CSL Behring
$150
GENZYME CORPORATION
$149
Takeda Pharmaceuticals U.S.A., Inc.
$109
Novartis Pharmaceuticals Corporation
$93
Mylan Specialty L.P.
$87
Blueprint Medicines Corporation
$78
ABBVIE INC.
$55
ADMA BioManufacturing LLC
$55
PFIZER INC.
$52
Hikma Pharmaceuticals USA
$40
Optinose US, Inc.
$30
kaleo, Inc.
$22
Phadia US Inc.
$17
Genentech USA, Inc.
$16
Top 3 companies account for 41.3% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$2,036
Regeneron Healthcare Solutions, Inc.
$1,806
Amgen Inc.
$1,636
GENZYME CORPORATION
$1,389
AstraZeneca Pharmaceuticals LP
$1,350
Pharming Healthcare, Inc.
$974
Grifols USA, LLC
$743
CSL Behring
$729
Takeda Pharmaceuticals U.S.A., Inc.
$668
Octapharma USA, Inc.
$596
PFIZER INC.
$476
Novartis Pharmaceuticals Corporation
$428
Boehringer Ingelheim Pharmaceuticals, Inc.
$406
Genentech USA, Inc.
$372
Mylan Specialty L.P.
$271
OptiNose US, Inc.
$266
kaleo, Inc.
$253
ALK-Abello, Inc
$250
Teva Pharmaceuticals USA, Inc.
$220
Optinose US, Inc.
$155
Stryker Corporation
$149
Kaleo, Inc.
$139
Shire North American Group Inc
$130
ABBVIE INC.
$125
Bio Products Laboratory USA, Inc.
$121
LEO Pharma Inc.
$120
Blueprint Medicines Corporation
$111
Phadia US Inc.
$72
ADMA BioManufacturing LLC
$55
Electromed, Inc.
$46
Incyte Corporation
$45
Horizon Therapeutics plc
$41
Hikma Pharmaceuticals USA
$40
Sunovion Pharmaceuticals Inc.
$37
AbbVie Inc.
$36
Horizon Pharma plc
$29
SANOFI-AVENTIS U.S. LLC
$19
Merck Sharp & Dohme LLC
$18
Covis Pharma GmBH
$13
Greer Laboratories, Inc.
$11
Top 3 companies account for 33.4% of all-time payments
Associated products mentioned in payments ›
ACTIMMUNE · ADBRY · AIRSUPRA · ALVESCO · AREXVY · AUVI-Q · AYVAKIT · AirDuo Digihaler · Auvi-Q · BEVESPI AEROSPHERE · BREO · BREZTRI · CIBINQO · CINQAIR · CUTAQUIG · CUVITRU · DALIRESP · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dymista · ENTELLUS - XPRESS ENT DILATION SYSTEM · EOHILIA · EUCRISA · FASENRA · FIRAZYR · Gammaplex · Gamunex-C · HYQVIA · Haegarda · Hizentra · ImmunoCAP · LONHALA MAGNAIR · NUCALA · OCTAGAM · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OPZELURA · ORALAIR · Odactra · PANZYGA · PRE-PEN · PREVNAR 20 · ProAir Digihaler · Prolastin-C · Prolastin-C Liquid · QVAR · RINVOQ · RUCONEST · Ryaltris · SHINGRIX · SMARTVEST · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · TAKHZYRO · TEZSPIRE · TRELEGY ELLIPTA · Utibron · XOLAIR · Xembify · Xhance · Xolair · YUPELRI · Yupelri
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Allergy & immunologists within 10 mi
72
Per 100K population
0.7
County median income
$87,760
Nearest hospital
KAISER FOUNDATION HOSPITAL - WEST LA
1.6 mi
1.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Sheinkopf is a mixed practice specialist, with above-average Medicare volume (top 17% in CA), with low-engagement industry engagement in the top 17% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Sheinkopf experienced with omalizumab injection (xolair) for asthma/allergy?
Based on Medicare claims data, Dr. Sheinkopf performed 5,385 omalizumab injection (xolair) for asthma/allergy services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sheinkopf receive payments from pharmaceutical companies?
Yes. Dr. Sheinkopf received a total of $16,383 from 40 companies across 723 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sheinkopf's costs compare to other allergy & immunologists in Los Angeles?
Dr. Sheinkopf's average Medicare payment per service is $25. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sheinkopf) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Allergy & Immunologists in Los Angeles
Browse allergy & immunologists in Los Angeles ranked by procedure volume and transparency data.
Highest volume
Top Allergy & Immunologists in CA
Allergy & immunologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Allergy & Immunologists in CA
Which CA allergy & immunologists receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Regeneron Healthcare Solutions, Inc. Payments to Doctors
See all physicians who received payments from Regeneron Healthcare Solutions, Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology